Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not gonna lie.
I went to both:
Jacobus Pharmaceutical CO
37 Cleveland Ln
Princeton
This is a home address. Nice house but is this a lab?
and
Jacobus Pharmaceutical CO
Schalks Crossing Rd
Plainsboro Township
This does not exist: Schalks Crossing Rd.
This is a road but and NO number was given. There are however different labs in the area like Bristol-Myers Squibb,Novo Nordisk Inc.and Xenobiotic.
I like this like but it is old:
http://www.fda.gov/downloads/ICECI/EnforcementActions/WarningLetters/1997/UCM065949.pdf
According to this I really don't think they practice GLP.
I like this company but I did jump out because I wanna make some cash and I'm not gonna go down with ship. Already made more than 100% and plan to make a STRONG CORE POSITION next week!
I just stop by Jacobus Pharmaceutical Company in Princeton. It is a home address . Look on google map.
I just stop by Jacobus Pharmaceutical Company in Princeton. It is a home address . Look on google map.
What were the other 2?
CPRX is looking strong now!
Great!
One last thing....to get approval in EU is much easier than the US. But I don't think it will be a problem.
I am still guessing but BMRN raise enough money to buy out Catalyst but that might not be the for BioMarin.
My second guess is Pfizer.
This should get interesting next week.
Dam Catalyst is up before me..... Lol
Early morning action
Nothing has change!
They need to read L2
Silly rabbit tricks are for kids!
You got it on a Black Friday sale!
Crazy day!
thrift shop
I don't think the FDA has anything to do with the shut down yet!
Right about that!
Indifferent because everyone is taking a beating.
A lot of sales going NOW but hopefully this will end soon.
About BMRN that's a different story......
I avg 1.35
might get some news at 12pm today!
Catalyst Pharmaceuticals tumbles ahead of presentation • 10:52 AM
Catalyst Pharmaceuticals (CPRX -8.2%) is sharply lower amid the release of presentation slides ahead of the company's appearance at 12 ET at the BIO Investor Forum.
The formerly high-flying biotech sector in general is having another tough day.
Good deal!
$CPRX
• Market Cap: ~$185MM (as of 10/3/13)
• Common S/O: 52.9MM shares**
• Cash and cash equivalents: ~$28MM*
• NASDAQ trading symbol: CPRX
• Top institutional holders: Federated,
New Leaf Venture Partners, OrbiMed,
and Millennium
• Strategic Investor: BioMarin
CPP-115: A Novel, Potent Molecule With
Superior Safety and Efficacy
$50-$100 MM market Opportunity for Infantile Spasms
• CPP-115-IS designed as oral therapy with better saf
ety &
tolerability to Vigabatrin
• Orphan drug indication in US & EU
• Leading therapies are not adequate
–
Acthar® Gel and Sabril®; generated $125MM
in 2012
• Affects 10,000-20,000 infants globally
–
5,000-10,000 in US
• Potential additional indications could increase mark
et
opportunity
–
Tourette’s Disorder (Large Orphan Indication)
• Phase I/II study ongoing at Mt. Sinai School of Medicin
e
• Top line results 1H 2014
–
Post-Traumatic Stress Disord
I believe it:
In conclusion, Catalyst appears to be an excellent speculation for significant price appreciation based on comparison to Aegerion and Acadia, and also based on the high likelihood of Firdapse being approved by the FDA in 2015. If Catalyst matches the performance of Aegerion and Acadia, and if market conditions remain stable, shares have the potential to appreciate to $41.66 in 12 to 18 months.
Strong Comps Indicate Catalyst Pharmaceutical Partners Outstanding Value Proposition
http://m.seekingalpha.com/article/1733532-strong-comps-indicate-catalyst-pharmaceutical-partners-outstanding-value-proposition?source=email_rt_article_readmore
Whole market down......Big sale and it's not even Black Friday!
Red to GREEN end of the day!
Catalyst Pharmaceutical Partners to Present at 12th Annual BIO Investor Forum ( October 8th at 9:00 am )
Gonna be HUGE!
Catalyst Pharmaceutical Partners to Present at 12th Annual BIO Investor Forum
http://www.marketwatch.com/story/catalyst-pharmaceutical-partners-to-present-at-12th-annual-bio-investor-forum-2013-10-04?reflink=MW_news_stmp
It will..............one day and soon!
=====================================>
I am with you on the levels today but I feel BioMarin is simply waiting on the FDA's decision on Firdapse.
Catalyst is currently in Phase III trial of Firdapse.
Firdapse is "currently approved" in the EU and is the FIRST AND ONLY approved drug for the symptomatic treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) in adults.
It is worth it to see====================>
This could be the next ACA$ in the making!
I don't get in to these plays for this reason!!!!
09/27/13
1:00 PM PT
Catalyst to Present at Aegis Capital 2013 Healthcare Conference
http://files.shareholder.com/downloads/CPRX/2699091196x7429947x693277/30db44f4-ade4-4ecd-8dee-8c33e4de1cf8/CPRX130927.pdf
We will see after today.
I will do some more research and do another article this weekend.
Holding till Buy Out!!!!!
From 2 days ago:
Catalyst Pharma rises as analyst sets 'Buy' rating
http://www.businessweek.com/ap/2013-09-24/catalyst-pharma-rises-as-analyst-sets-buy-rating
Love the Pic!
Congrat$
You are AWESOME G!
WOW I just might have to follow you instead of Supertrades!
Wow GR11 looks like you have more work!